IRIS UniCatt

Vita, Emanuele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 946
AS - Asia 892
EU - Europa 614
SA - Sud America 219
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.702
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 898
SG - Singapore 404
IT - Italia 189
CN - Cina 184
BR - Brasile 178
SE - Svezia 104
VN - Vietnam 100
DE - Germania 67
FR - Francia 56
IN - India 49
GB - Regno Unito 39
FI - Finlandia 28
AR - Argentina 23
CA - Canada 23
JP - Giappone 22
NL - Olanda 22
ID - Indonesia 21
HK - Hong Kong 20
IE - Irlanda 18
KR - Corea 18
MX - Messico 16
RU - Federazione Russa 15
TR - Turchia 14
AT - Austria 13
BD - Bangladesh 13
IQ - Iraq 12
PL - Polonia 12
CZ - Repubblica Ceca 10
ES - Italia 8
ZA - Sudafrica 8
EC - Ecuador 7
UA - Ucraina 7
LT - Lituania 6
CO - Colombia 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
CI - Costa d'Avorio 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
IR - Iran 3
UZ - Uzbekistan 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
IL - Israele 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
RO - Romania 2
UY - Uruguay 2
BH - Bahrain 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GI - Gibilterra 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
ML - Mali 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 2.702
Salva come PNG Salva come JPEG
Città #
Singapore 250
Ashburn 129
San Jose 96
Rome 67
Chandler 56
New York 54
Hefei 39
Ho Chi Minh City 39
Los Angeles 36
Hyderabad 35
The Dalles 32
Council Bluffs 27
Beijing 26
St Louis 25
Hanoi 23
Milan 22
Tokyo 22
Frankfurt am Main 20
Dallas 19
Lauterbourg 19
São Paulo 19
Boardman 18
Dublin 18
Hong Kong 18
Jakarta 17
Munich 17
Cattolica 16
Seoul 16
Santa Clara 15
Buffalo 14
Helsinki 13
Kent 11
Orem 11
Brno 9
Chicago 9
Paris 9
Turku 9
Brooklyn 8
Düsseldorf 8
Montreal 8
Moscow 8
Vienna 8
Warsaw 8
Atlanta 7
Boston 7
Denver 7
San Mateo 7
Stockholm 7
Amsterdam 6
Bexley 6
Bremen 6
Da Nang 6
Des Moines 6
Lappeenranta 6
Phoenix 6
Poplar 6
Princeton 6
Johannesburg 5
London 5
Marseille 5
Quito 5
Toronto 5
Abidjan 4
Amman 4
Baghdad 4
Brussels 4
Falkenstein 4
Goiânia 4
Guangzhou 4
Haiphong 4
Madrid 4
Mexico City 4
Middlesbrough 4
North Bergen 4
Nuremberg 4
Odesa 4
Orangeburg 4
Portsmouth 4
Riyadh 4
Seattle 4
Wroclaw 4
Ankara 3
Bắc Ninh 3
Campinas 3
Charlotte 3
Chennai 3
Cuiabá 3
Erbil 3
Fairfield 3
Houston 3
Huzhou 3
Manaus 3
Manchester 3
Ottawa 3
Petrozavodsk 3
Piracicaba 3
Querétaro 3
Santo André 3
Starnberg 3
Wilmington 3
Totale 1.570
Salva come PNG Salva come JPEG
Nome #
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 175
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study 172
From palliation to cure: PIPAC for peritoneal malignancies 152
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced nonsmall cell lung cancer 144
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 139
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 138
Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities 137
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non–small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 134
Prognostic factors and long-term survival in locally advanced nsclc with pathological complete response after surgical resection following neoadjuvant therapy 132
Oncogene-addicted non-small-cell lung cancer: Treatment opportunities and future perspectives 132
Comparative Analysis of Comprehensive Genomic Profile in Thymomas and Recurrent Thymomas Reveals Potentially Actionable Mutations for Target Therapies 119
Role of Peripheral Blood Markers for Detecting Response and Predicting Prognosis in Patients with Non-small-cell Lung Cancer Undergoing Neoadjuvant Therapy and Surgery 116
Clinical Stage III NSCLC Patients Treated with Neoadjuvant Therapy and Surgery: The Prognostic Role of Nodal Characteristics 115
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 113
Leptin-mediated meta-inflammation may provide survival benefit in patients receiving maintenance immunotherapy for extensive-stage small cell lung cancer (ES-SCLC) 109
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 108
Implementation of Artificial Intelligence in Personalized Prognostic Assessment of Lung Cancer: A Narrative Review 107
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results 106
PD-L1 for selecting non-small-cell lung cancer patients for first-line immuno-chemotherapy combination: A systematic review and meta-analysis 106
Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis 99
Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma 83
Surgery after induction chemo or immunotherapy for locally advanced NSCLC 81
Network analysis of NRG1 variants of uncertain significance (VUSes) in advanced non-small-cell lung cancer and their prognostic role in EGFR-mutant patients treated with first-line osimertinib 15
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice 11
Primary adrenal insufficiency induced by immune checkpoint inhibitors (ICIs): a case series and systematic literature review 3
Totale 2.746
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/202272 20 0 1 14 1 1 0 8 2 2 8 15
2022/2023157 21 20 13 27 9 23 11 8 18 0 2 5
2023/2024203 3 35 9 10 8 18 26 9 2 21 21 41
2024/2025679 23 6 41 34 42 30 32 20 85 109 146 111
2025/20261.612 180 78 110 259 295 69 215 83 114 106 94 9
Totale 2.746